DEVELOPMENT OF A CANCER RECURRENCE RISK INDEX (CRI) AFTER LIVER TRANSPLANTATION FOR HEPATOCELLULAR CARCINOMA: IMPLICATIONS FOR POST-TRANSPLANT SURVEILLANCE AND ADJUVANT THERAPY

被引：0
|
作者：
Roayaie, Kayvan [1 ]
Sapisochin, Gonzalo [1 ]
Fix, Oren K. [1 ]
Roberts, John P. [1 ]
Yao, Francis Y. [1 ]
机构：
[1] UCSF, San Francisco, CA USA
来源：
HEPATOLOGY | 2010年 / 52卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1074
引用
收藏
页码：838A / 838A
页数：1
相关论文
共 50 条
  • [21] Late Recurrence of Hepatocellular Carcinoma after Liver Transplantation: Is an Active Surveillance for Recurrence Needed?
    Castroagudin, J. F.
    Molina-Perez, E.
    Ferreiro-Iglesias, R.
    Abdulkader, I.
    Otero-Anton, E.
    Tome, S.
    Varo-Perez, E.
    TRANSPLANTATION PROCEEDINGS, 2012, 44 (06) : 1565 - 1567
  • [22] Chemoembolization therapy of hepatocellular carcinoma prior to liver transplant is associated with the development of post-transplant biliary anastomotic strictures
    Kanakadandi, Vijay
    Park, James
    Ahmad, Jawad
    HEPATOLOGY, 2012, 56 : 475A - 476A
  • [23] Post-Transplant Recurrence Following Yttrium-90 Treatment in Liver Transplant Recipients with Hepatocellular Carcinoma
    Rizzo, O.
    Kitajima, T.
    Kavousi, M.
    Yeddula, S.
    Rizzari, M.
    Collins, K.
    Yoshida, A.
    Abouljoud, M. S.
    Nagai, S.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2020, 20 : 1057 - 1057
  • [24] Recurrence of Hepatocellular Carcinoma after Liver Transplantation: Recurrence Characteristics and Risk Factors
    Li, Chuan
    Wen, Tian-Fu
    Liao, Zhi-Xue
    Yan, Lv-Nan
    Li, Bo
    Zeng, Yong
    Wang, Wen-Tiao
    Xu, Ming-Qing
    Yang, Jia-Ying
    Wei, Yong-Gang
    HEPATO-GASTROENTEROLOGY, 2010, 57 (99-100) : 567 - 570
  • [25] Peri-Operative Basiliximab is Not Associated with Post-Transplant Hepatocellular Carcinoma Recurrence in Liver Transplant Recipients
    Salerno, D.
    Lange, N.
    Simoneau, E.
    Sammons, C.
    Bley, D.
    Brown, R. S., Jr.
    Emond, J.
    Halazun, K.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2019, 19 : 1071 - 1072
  • [26] Liver transplantation in a child with multifocal hepatocellular carcinoma hepatitis C and management of post-transplant viral recurrence using boceprevir
    Malik, Saloni
    Dekio, Fumiko
    Wen, Jessica W.
    PEDIATRIC TRANSPLANTATION, 2014, 18 (02) : E64 - E68
  • [27] A Proposed Surveillance Strategy for Hepatocellular Carcinoma Recurrence after Liver Transplantation.
    Levi, D.
    Russo, M.
    Uchida, K.
    Nishida, S.
    Tzakis, A.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 : 244 - 244
  • [28] What Is the Role of Adjuvant Therapy After Liver Transplantation for Hepatocellular Carcinoma?
    Duvoux, Christophe
    Kiuchi, Tetsuya
    Pestalozzi, Bernhard
    Busuttil, Ronald
    Miksad, Rebecca
    LIVER TRANSPLANTATION, 2011, 17 : S147 - S158
  • [29] Risk factors and management of post-liver transplant recurrence of hepatocellular carcinoma
    Rammohan, Ashwin
    Rela, Mohamed
    HEPATOMA RESEARCH, 2021, 7
  • [30] Post-Transplant Alpha-Fetoprotein Slope: A Strong Predictor of Hepatocellular Carcinoma Recurrence and Survival after Transplantation.
    Dumitra, Teodora
    Dumitra, Sinziana
    Barkun, Jeffrey
    Metrakos, Peter
    Chaudhury, Prosanto
    Paraskevas, Steven
    Deschenes, Marc
    Tchervenkov, Jean
    LIVER TRANSPLANTATION, 2013, 19 : S222 - S222
12345